blinky
08-07

$Eli Lilly(LLY)$ In Big Pharma's growth rankings Eli Lilly took top spot away from Novo Nordisk in Q1

and they will do it again in Q2.

NVO $Novo-Nordisk A/S(NVO)$ missed. Lilly won't miss

Facts matter! Look at last quarter to see how it played out.

Q1: Novo Nordisk dropped out of the top spot with its 22% YOY increase

Lilly took over as No. 1 thanks to its 28% quarterly boost.

They will do it again and beat NVO

Think Winnie The Pooh GIFThink Winnie The Pooh GIF

LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?
Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading. Novo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss. ------------ Which weight loss drug company is a better buy?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment